| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 147.8K | $3.82M | - | |
| Other | 133.1K | $3.44M | - | |
| CEO | 132.7K | $3.43M | - | |
| CFO | 105.7K | $2.73M | - | |
| VP | 95.7K | $2.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2021 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 700 | $113.67 | $79,572.07 | -1.3% | -21.1% | -49.8% | |
| May 6, 2021 | Huang Dennis Karl63 | EVP &Chief Tech Ops Officer | Sell | 363 | $113.68 | $41,265.84 | -0.9% | -26.2% | -50.3% | |
| May 6, 2021 | Parschauer Karah Herdman77 | EVP And General Counsel | Sell | 313 | $113.67 | $35,578.71 | -1.0% | -26.2% | -50.3% | |
| May 6, 2021 | Pinion John Richard73 | See Remarks | Sell | 363 | $113.69 | $41,269.47 | -0.7% | -26.2% | -50.3% | |
| May 6, 2021 | Huizenga Theodore Alan65 | SVP, Chief Accounting Officer | Sell | 142 | $113.67 | $16,141.14 | -0.9% | -26.2% | -50.3% | |
| May 6, 2021 | Kassberg Thomas Richard68 | Cbo &EVP | Sell | 363 | $113.69 | $41,269.47 | -0.3% | -26.2% | -50.3% | |
| May 6, 2021 | Bedrosian Camille L64 | EVP And Chief Medical Officer | Sell | 364 | $113.67 | $41,375.88 | -0.9% | -26.2% | -50.3% | |
| May 3, 2021 | Kakkis Emil D72 | President &CEO | Sell | 30,000 | $107.80 | $3,234,000.00 | -1.3% | -24.1% | -32.9% | |
| Apr 20, 2021 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 396 | $104.28 | $41,294.88 | -1.4% | -19.7% | -25.0% | |
| Apr 15, 2021 | Bedrosian Camille L64 | EVP And Chief Medical Officer | Sale+OE | 5,000 | $109.09 | $545,450.00 | -11.3% | -22.7% | -22.1% |